CCL22 and neoplasm: In order to explore the changes in the function of macrophages following treatment with CM or Etanercept, the effect of Etanercept on the expression levels of TNF-α as well as CCL22, a chemokine marker of M2 phenotype of tumor-associated macrophages contributing to aggressive features of tumors, were measured [25].